Guerbet is a global specialist in contrast media and solutions for diagnostic and interventional radiology, and we are particularly involved in liver cancer treatment, as well as embolization of vascular anomalies.
In early 2018, Guerbet acquired Accurate Medical Therapeutics (“Accurate”). Accurate developed a range of microcatheters for embolization procedures on tumors or vascular diseases.
Guerbet has also invested in microspheres technology, which aims to supplement existing interventional imaging solutions and to offer significant synergies with our range of microcatheters.
Overall, the focus of our Interventional Imaging franchise is to provide interventional radiologists with innovative image-guided and minimally invasive solutions that help both advance the treatment of patients and improve their outcomes.